Literature DB >> 10852278

The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study.

K C Lin1, H Y Lin, P Chou.   

Abstract

OBJECTIVE: To investigate the incidence of gout and the interaction between uric acid level and other risk factors in the development of gout.
METHODS: Two hundred twenty-three asymptomatic hyperuricemic men initially studied in 1991-92 were reassessed in 1996-97. Gout was clinically diagnosed by a senior rheumatologist based on history and physical according to the clinical criteria of Wallace. Basic demographic and lifestyle variables as well as biochemical data were collected in both baseline and followup periods. Both the stability analysis and the analysis of repeated relationships were applied.
RESULTS: The 5-year cumulative incidence of gout was 18.83% (42/223). The risk factors for gout based on the analysis of repeated relationships were uric acid level, alcohol consumption, use of diuretics, and obesity. The only predictor of gout at baseline was uric acid level. After adjusting for baseline uric acid level, followup uric acid increase, persistent alcohol consumption, use of diuretics in the followup period, and body mass index increase were independent predictors for gout among asymptomatic hyperuricemic men. Excessive alcohol consumption, particularly if occasional, was the most important factor in the development of gout, even when the concentration of uric acid level was below 8 mg/dl.
CONCLUSION: Uric acid level is the key factor for prevention of gout and needs constant monitoring. Other contributing or possible etiologic factors such as alcohol consumption, diuretics use, and excess weight gain carry an increased risk of gout attack among patients with hyperuricemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10852278

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  65 in total

1.  Association between gout and polymorphisms in GCKR in male Han Chinese.

Authors:  Jing Wang; Shiguo Liu; Binbin Wang; Zhimin Miao; Lin Han; Nan Chu; Kun Zhang; Dongmei Meng; Changgui Li; Xu Ma
Journal:  Hum Genet       Date:  2012-03-07       Impact factor: 4.132

Review 2.  Gout in solid organ transplantation: a challenging clinical problem.

Authors:  Lisa Stamp; Martin Searle; John O'Donnell; Peter Chapman
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Diagnosis and management of gout: a rational approach.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

Review 4.  Risk factors for gout and prevention: a systematic review of the literature.

Authors:  Jasvinder A Singh; Supriya G Reddy; Joseph Kundukulam
Journal:  Curr Opin Rheumatol       Date:  2011-03       Impact factor: 5.006

5.  Study on the diagnosis of gout with xanthine and hypoxanthine.

Authors:  Yu Wang; Miao Deng; Binge Deng; Liming Ye; Xiaofan Fei; Zhigang Huang
Journal:  J Clin Lab Anal       Date:  2019-02-25       Impact factor: 2.352

Review 6.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 7.  Management of acute and chronic gouty arthritis: present state-of-the-art.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  The degree of asymptomatic hyperuricemia and the risk of gout. A retrospective analysis of a large cohort.

Authors:  Hadar Duskin-Bitan; Eytan Cohen; Elad Goldberg; Tzippy Shochat; Amos Levi; Moshe Garty; Ilan Krause
Journal:  Clin Rheumatol       Date:  2014-02-13       Impact factor: 2.980

9.  Cost-Effectiveness Analysis of Lesinurad/Allopurinol Versus Febuxostat for the Management of Gout/Hyperuricemia in Italy.

Authors:  M Ruggeri; M Basile; C Drago; F R Rolli; A Cicchetti
Journal:  Pharmacoeconomics       Date:  2018-05       Impact factor: 4.981

Review 10.  Gout.

Authors:  Martin Underwood
Journal:  BMJ Clin Evid       Date:  2008-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.